Explore more publications!
Middle East News Watch
Got News to Share?

Middle East News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 5, 2025

Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures
December 5, 2025

Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures

Indeterminate GlobeNewswire
Paribu has acquired CoinMENA, MENA’s largest local crypto exchange, in a transaction valued at up to USD 240 million
December 5, 2025

Paribu has acquired CoinMENA, MENA’s largest local crypto exchange, in a transaction valued at up to USD 240 million

Indeterminate GlobeNewswire
Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad
December 5, 2025

Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad

Indeterminate GlobeNewswire
DeFi Crypto Mutuum Finance (MUTM) Reports Key Roadmap Phase 2 Milestones Passed Ahead of Q4 Launch
December 5, 2025

DeFi Crypto Mutuum Finance (MUTM) Reports Key Roadmap Phase 2 Milestones Passed Ahead of Q4 Launch

Indeterminate GlobeNewswire
New Crypto Mutuum Finance (MUTM) Nears $19.5M in Funding as V1 Q4 Timeline Remains on Track
December 5, 2025

New Crypto Mutuum Finance (MUTM) Nears $19.5M in Funding as V1 Q4 Timeline Remains on Track

Indeterminate GlobeNewswire
GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models
December 5, 2025

GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models

Indeterminate GlobeNewswire
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease
December 5, 2025

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease

Indeterminate GlobeNewswire
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 5, 2025

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
ParaZero Signs Strategic Distribution Agreement, Significantly Expanding Reach into Western European NATO Defense Markets
December 5, 2025

ParaZero Signs Strategic Distribution Agreement, Significantly Expanding Reach into Western European NATO Defense Markets

Indeterminate GlobeNewswire
Nexxen to Participate in Raymond James TMT and Consumer Conference on December 9, 2025
December 5, 2025

Nexxen to Participate in Raymond James TMT and Consumer Conference on December 9, 2025

Indeterminate GlobeNewswire
Mirasol Announces Change in Chief Financial Officer
December 5, 2025

Mirasol Announces Change in Chief Financial Officer

Indeterminate GlobeNewswire
Koryx Copper Provides Update on Zambia Projects with Definition of Drill Targets at Luanshya West and Completion of Regional Surface Geochemistry at Mpongwe
December 5, 2025

Koryx Copper Provides Update on Zambia Projects with Definition of Drill Targets at Luanshya West and Completion of Regional Surface Geochemistry at Mpongwe

Indeterminate GlobeNewswire
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 5, 2025

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
AstroX Launches the First Livestream-Powered Multichain Platform, Redefining the Web3 Creator Economy
December 5, 2025

AstroX Launches the First Livestream-Powered Multichain Platform, Redefining the Web3 Creator Economy

Indeterminate GlobeNewswire
Sapu Nano Announce Deciparticle™ Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
December 5, 2025

Sapu Nano Announce Deciparticle™ Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions